v3.25.2
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2024
OPERATING ACTIVITIES          
(Loss)/ Profit for the period $ (1,591,064) $ 9,777,309 $ (7,183,876) $ 8,337,346  
Adjustments to reconcile profit to net cash flows          
Income tax     (5,471,555) 7,806,595  
Financial results     23,875,879 19,193,389  
Depreciation of property, plant and equipment     4,495,318 3,923,274  
Amortization of intangible assets     8,889,514 8,235,478  
Depreciation of leased assets     3,888,743 2,526,174  
Transactional expenses     984,350    
Share-based incentive and stock options     3,353,145 11,481,363  
Share of profit or loss of joint ventures and associates 943,603 (906,136) 1,169,766 (4,467,103)  
Provisions for contingencies     209,228 362,248  
Allowance for impairment of trade debtors     1,849,836 463,688  
Allowance for obsolescence     1,112,743 335,763  
Initial recognition and changes in the fair value of biological assets     (1,578,993) (281,372)  
Changes in the net realizable value of agricultural products after harvest     423,115 2,021,747  
Gain on sale of equipment and intangible assets     (7,694,896) (87,599)  
Working capital adjustments          
Trade receivables     7,508,407 (48,428,426)  
Other receivables     282,729 (2,721,910)  
Income and minimum presumed income taxes     (7,316,783) 4,623,067  
Inventories and biological assets     32,839,986 7,577,552  
Trade and other payables     (42,277,274) 16,662,579  
Employee benefits and social security     (362,311) (1,791,169)  
Deferred revenue and advances from customers     (549,338) (18,613,875)  
Interest collected     4,592,116 1,408,277  
Inflation effects on working capital adjustments     97,797 (107,285)  
Net cash flows generated by operating activities     23,137,646 18,459,801  
INVESTMENT ACTIVITIES          
Proceeds from sale of property, plant and equipment     170,802 167,868  
Proceeds from financial assets     14,740,468    
Investment in financial assets     (10,099,929) (11,873,696)  
Purchase of property, plant and equipment     (5,211,492) (7,773,443)  
Capitalized development expenditures     (6,902,069) (7,867,528)  
Purchase of intangible assets     (312,974) (1,086,398)  
Net cash flows used by investing activities     (7,615,194) (28,433,197)  
FINANCING ACTIVITIES          
Proceeds from borrowings     140,058,194 139,750,796  
Repayment of borrowings and financed payments     (140,753,656) (131,671,711)  
Interest payments     (16,709,014) (16,806,711)  
Other financial payments     (2,199,702) (1,800,597)  
Purchase of own shares     (926,899) (734,388)  
Leased assets payments     (4,392,517) (3,939,771)  
Cash dividend distributed by subsidiary     (72,051) (174,800)  
Net cash flows used by financing activities     (24,995,645) (15,377,182)  
Net decrease in cash and cash equivalents     (9,473,193) (25,350,578)  
Inflation effects on cash and cash equivalents     2,325 (23,071)  
Cash and cash equivalents as of beginning of the period     44,473,270 48,129,194 $ 48,129,194
Effect of exchange rate changes on cash and equivalents     3,454,587 (6,394,346)  
Cash and cash equivalents as of the end of the period $ 38,456,989 $ 16,361,199 $ 38,456,989 $ 16,361,199 $ 44,473,270